Mark R. Dixon - Concepedia

Author

Mark R. Dixon

Southern Illinois University Carbondale ORCID

Also Known As

DIXON, MARK, Dixon, M., Dixon, Mark, M. Dixon, M. R. DIXON, MARK R. DIXON, Mark Dixon, Mark R Dixon, Mark R. Dixon, W Johnson

188

Publications

4.4K

Citations

H-Index

214

Concepts

All Affiliations

Southern Illinois University Carbondale University of Nevada, Reno University of Illinois Chicago Missouri State University

About

Mark R. Dixon is an author at Southern Illinois University Carbondale specializing in social sciences, psychology, and behavioral sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Education	17	22	842
2	Business	4	4	502
3	Engineering	4	4	139
4	Health Sciences	3	3	72
5	Arts	1	1	34

Mark R. Dixon

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Michael Dickinson, Carmelo Carlo‐Stella, Franck Morschhauser, New England Journal of Medicine	2022	605
DELAY DISCOUNTING BY PATHOLOGICAL GAMBLERS Mark R. Dixon, Janice Marley, Eric A. Jacobs Journal of Applied Behavior Analysis Behavioral Decision MakingGame TheoryImpulsivitySocial SciencesPsychology	2003	439
CONTEXTUAL CONTROL OF DELAY DISCOUNTING BY PATHOLOGICAL GAMBLERS Mark R. Dixon, Eric A. Jacobs, Scott Sanders Journal of Applied Behavior Analysis	2006	203
Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies Dragana Bugarski‐Kirola, Thomas Blaettler, Celso Arango, Biological Psychiatry Daylyte StudiesPsychiatryPsychotic DisorderPsychopharmacologySchizophrenia	2016	137
Report of the ACBS Task Force on the strategies and tactics of contextual behavioral science research Steven C. Hayes, Rhonda M. Merwin, Louise McHugh, Journal of Contextual Behavioral Science	2021	126
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial Jeremy S. Abramson, Matthew Ku, Mark P. Hertzberg, The Lancet Hematological MalignancyOpen-label TrialLymphoid NeoplasiaMedicineImmunology	2024	114
NEUROBEHAVIORAL EVIDENCE FOR THE “NEAR‐MISS” EFFECT IN PATHOLOGICAL GAMBLERS Reza Habib, Mark R. Dixon Journal of the Experimental Analysis of Behavior NeuropsychologyBehavioral Decision MakingBrain FunctionNeurolinguisticsAffective Neuroscience	2010	112
USING A SELF‐CONTROL TRAINING PROCEDURE TO INCREASE APPROPRIATE BEHAVIOR Mark R. Dixon, Linda J. Hayes, Lisa M. Binder, Journal of Applied Behavior Analysis	1998	101
Randomized controlled trial of a brief acceptance and commitment training for parents of individuals diagnosed with autism spectrum disorders Adam D. Hahs, Mark R. Dixon, Dana Paliliunas Journal of Contextual Behavioral Science Family MedicineBehavioral SupportCommitment TrainingAutism Spectrum DisordersClinical Psychology	2018	87
A PROCEDURE TO TEACH SELF‐CONTROL TO CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER Lisa M. Binder, Mark R. Dixon Journal of Applied Behavior Analysis	2000	72

Page 1